279 related articles for article (PubMed ID: 27348241)
1. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8.
Monterrubio C; Paco S; Olaciregui NG; Pascual-Pasto G; Vila-Ubach M; Cuadrado-Vilanova M; Ferrandiz MM; Castillo-Ecija H; Glisoni R; Kuplennik N; Jungbluth A; de Torres C; Lavarino C; Cheung NKV; Mora J; Sosnik A; Carcaboso AM
J Control Release; 2017 Jun; 255():108-119. PubMed ID: 28412222
[TBL] [Abstract][Full Text] [Related]
3. SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody.
Liu Y; Jin X; Lan X; Lang J; Wen Q; An R
Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):216-224. PubMed ID: 27387378
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody.
Zhao L; Yang Y; Zhou P; Ma H; Zhao X; He X; Wang T; Zhang J; Liu Y; Zhang T
J Immunother; 2015; 38(6):217-28. PubMed ID: 26049545
[TBL] [Abstract][Full Text] [Related]
6. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.
Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J
J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962
[TBL] [Abstract][Full Text] [Related]
7. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.
Stratford EW; Bostad M; Castro R; Skarpen E; Berg K; Høgset A; Myklebost O; Selbo PK
Biochim Biophys Acta; 2013 Aug; 1830(8):4235-43. PubMed ID: 23643966
[TBL] [Abstract][Full Text] [Related]
8. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Zhou J; Sun J; Chen H; Peng Q
Int J Oncol; 2018 Sep; 53(3):1289-1300. PubMed ID: 30015824
[TBL] [Abstract][Full Text] [Related]
9. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
10. The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies.
Chen H; Lin J; Shan Y; Zhengmao L
Biomed Pharmacother; 2019 Jul; 115():108857. PubMed ID: 31048191
[TBL] [Abstract][Full Text] [Related]
11. Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine.
Schmid D; Fay F; Small DM; Jaworski J; Riley JS; Tegazzini D; Fenning C; Jones DS; Johnston PG; Longley DB; Scott CJ
Mol Ther; 2014 Dec; 22(12):2083-2092. PubMed ID: 25200008
[TBL] [Abstract][Full Text] [Related]
12. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
[TBL] [Abstract][Full Text] [Related]
15. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
[TBL] [Abstract][Full Text] [Related]
16. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
17. Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy.
Yang X; Xue X; Luo Y; Lin TY; Zhang H; Lac D; Xiao K; He Y; Jia B; Lam KS; Li Y
J Control Release; 2017 Sep; 261():297-306. PubMed ID: 28700898
[TBL] [Abstract][Full Text] [Related]
18. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
[TBL] [Abstract][Full Text] [Related]
19. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
[TBL] [Abstract][Full Text] [Related]
20. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.
Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z
Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
